David Malcom Rodman
Chief Medical Officer · 19 filings · Latest: Aug 10, 2026
Mineralys Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MLYS | Rodman David Malcom | — | Oct 13, 2026 | Proposed Sale | $22.04 | 3,542 | $78.1K | — | |
MLYS | Rodman David Malcom | — | Sep 17, 2026 | Proposed Sale | $27.95 | 417 | $11.7K | — | |
MLYS | Rodman David Malcom | — | Sep 14, 2026 | Proposed Sale | $28.14 | 7,709 | $216.9K | — | |
MLYS | Rodman David Malcom | — | Sep 9, 2026 | Proposed Sale | $30.87 | 2,171 | $67.0K | — | |
MLYS | Rodman David Malcom | — | Aug 17, 2026 | Proposed Sale | $25.46 | 417 | $10.6K | — | |
MLYS | Rodman David Malcom | — | Aug 13, 2026 | Proposed Sale | $26.48 | 14,056 | $372.2K | — | |
MLYS | David Malcom Rodman | Chief Medical Officer | Aug 10, 2026 | Sale | $27.09 | 2,170 | $58.8K | 51,384 | |
MLYS | David Malcom Rodman | Chief Medical Officer | Aug 10, 2026 | Option Exercise | $16.00 | 2,170 | $34.7K | 53,554 | |
MLYS | Rodman David Malcom | — | Aug 10, 2026 | Proposed Sale | $27.09 | 2,170 | $58.8K | — | |
MLYS | David Malcom Rodman | Chief Medical Officer | Jul 17, 2026 | Sale | $26.53 | 416 | $11.0K | 51,384 | |
MLYS | David Malcom Rodman | Chief Medical Officer | Jul 17, 2026 | Option Exercise | $15.44 | 416 | $6.4K | 51,800 | |
MLYS | Rodman David Malcom | — | Jul 17, 2026 | Proposed Sale | $26.48 | 416 | $11.0K | — | |
MLYS | David Malcom Rodman | Chief Medical Officer | Jul 15, 2026 | Sale | $26.61 | 6,349 | $169.0K | 51,384 | |
MLYS | David Malcom Rodman | Chief Medical Officer | Jul 13, 2026 | Sale | $27.58 | 14,058 | $387.7K | 57,733 | |
MLYS | David Malcom Rodman | Chief Medical Officer | Jul 13, 2026 | Option Exercise | $7.28 | 14,058 | $102.4K | 71,791 | |
MLYS | Rodman David Malcom | — | Jul 15, 2026 | Proposed Sale | $26.61 | 6,349 | $169.0K | — | |
MLYS | Rodman David Malcom | — | Jul 13, 2026 | Proposed Sale | $27.58 | 14,058 | $387.7K | — | Jul 14 3:08 PM 144/A |
MLYS | Rodman David Malcom | — | Jul 13, 2026 | Proposed Sale | $26.72 | 14,508 | $387.7K | — | |
MLYS | David Malcom Rodman | Chief Medical Officer | Jul 9, 2026 | Sale | $30.30 | 2,171 | $65.8K | 57,733 | |
MLYS | David Malcom Rodman | Chief Medical Officer | Jul 9, 2026 | Option Exercise | $16.00 | 2,171 | $34.7K | 59,904 |
Page 1 of 5
Next →